These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2193838

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W, Grillo N.
    Minerva Med; 1985 May 12; 76(19-20):945-53. PubMed ID: 3158842
    [Abstract] [Full Text] [Related]

  • 25. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986 May 12; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Van Bortel LM.
    Drug Saf; 2009 May 12; 32(4):283-91. PubMed ID: 19388720
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct 12; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J, Intaglietta M, Messmer K.
    Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426
    [Abstract] [Full Text] [Related]

  • 38. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B, Grünberger J, Linzmayer L, Stöhr H.
    Int J Clin Pharmacol Res; 1984 Nov 04; 4(2):95-107. PubMed ID: 6469443
    [Abstract] [Full Text] [Related]

  • 39. The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry.
    Kjaergaard JJ, Ditzel J.
    Int J Microcirc Clin Exp; 1987 Aug 04; 6(3):257-63. PubMed ID: 3308731
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.